MX2020004587A - Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt. - Google Patents
Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt.Info
- Publication number
- MX2020004587A MX2020004587A MX2020004587A MX2020004587A MX2020004587A MX 2020004587 A MX2020004587 A MX 2020004587A MX 2020004587 A MX2020004587 A MX 2020004587A MX 2020004587 A MX2020004587 A MX 2020004587A MX 2020004587 A MX2020004587 A MX 2020004587A
- Authority
- MX
- Mexico
- Prior art keywords
- arm
- anticodon
- stop codons
- trna
- acceptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
En ciertas modalidades, la presente invención proporciona un ARN de transferencia (ARNt) modificado que comprende un brazo T, un brazo D, un brazo de anticodón y un brazo aceptor, en donde el brazo T comprende nucleótidos que interaccionan con la proteína del factor de elongación 1 alfa 1, y métodos de uso del mismo. En ciertas modalidades, la presente invención provee un ARN de transferencia (ARNt) modificado que comprende un brazo T, un brazo D, un brazo anticodón y un brazo aceptor, (a) en donde el brazo anticodón comprende un anticodón trinucleotídico, en donde el anticodón es 5'-UCA-3' y reconoce codones de paro TGA, y en donde el brazo aceptor está enlazado operativamente a una arginina, triptófano o glicina; (b) en donde el brazo anticodón comprende un anticodón trinucleotídico, en donde el anticodón es 5'-UUA-3' y reconoce codones de paro TAA, y en donde el brazo aceptor está enlazado operativamente a una glutamina o glutamato; o (c) en donde el brazo anticodón comprende un anticodón trinucleotídico, en donde el anticodón es 5'-CUA-3' y reconoce codones de paro TAG, y en donde el brazo aceptor está enlazado operativamente a un triptófano, glutamato o glutamina.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762580887P | 2017-11-02 | 2017-11-02 | |
| US201862687015P | 2018-06-19 | 2018-06-19 | |
| PCT/US2018/059065 WO2019090154A1 (en) | 2017-11-02 | 2018-11-02 | Methods of rescuing stop codons via genetic reassignment with ace-trna |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020004587A true MX2020004587A (es) | 2021-04-12 |
Family
ID=66332719
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020004587A MX2020004587A (es) | 2017-11-02 | 2018-11-02 | Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt. |
| MX2020004647A MX2020004647A (es) | 2017-11-02 | 2018-11-02 | Métodos de rescate de codones de detención por medio de reasignación genética con arn de transferencia editado anti-codones (ace-trna). |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020004647A MX2020004647A (es) | 2017-11-02 | 2018-11-02 | Métodos de rescate de codones de detención por medio de reasignación genética con arn de transferencia editado anti-codones (ace-trna). |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US11661600B2 (es) |
| EP (2) | EP3703762A4 (es) |
| JP (6) | JP2021502078A (es) |
| KR (2) | KR102857378B1 (es) |
| CN (3) | CN119286852A (es) |
| AU (2) | AU2018360055B2 (es) |
| BR (2) | BR112020008725A2 (es) |
| CA (2) | CA3081692A1 (es) |
| IL (3) | IL274356B1 (es) |
| MX (2) | MX2020004587A (es) |
| RU (2) | RU2020117928A (es) |
| WO (2) | WO2019090169A1 (es) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| KR20240007715A (ko) | 2016-10-14 | 2024-01-16 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| WO2018165504A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| KR20190123328A (ko) | 2017-03-09 | 2019-10-31 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 암 백신 |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| EP3658573A1 (en) | 2017-07-28 | 2020-06-03 | President and Fellows of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| MX2020004587A (es) | 2017-11-02 | 2021-04-12 | Univ Iowa Res Found | Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt. |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| WO2020069194A1 (en) * | 2018-09-26 | 2020-04-02 | Case Western Reserve University | Methods and compositions for treating a premature stop codon-mediated disorder |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| EP4041317A4 (en) * | 2019-10-11 | 2024-05-22 | University of Massachusetts | RAAV-MEDIATED IN VIVO ADMINISTRATION OF ARNT SUPPRESSANTS |
| JP7712270B2 (ja) * | 2019-11-01 | 2025-07-23 | テバード バイオサイエンシズ インコーポレイテッド | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| JP2023504661A (ja) * | 2019-12-02 | 2023-02-06 | シェイプ・セラピューティクス・インコーポレイテッド | 疾患の処置のための標的化トランスファーｒｎａ |
| BR112022020780A2 (pt) * | 2020-04-14 | 2022-11-29 | Flagship Pioneering Innovations Vi Llc | Composições de trem e usos das mesmas |
| JP2023533174A (ja) * | 2020-06-12 | 2023-08-02 | ユニバーシティ オブ ロチェスター | ＡＣＥ－ｔＲＮＡのコード化及び発現 |
| KR20230135585A (ko) * | 2020-12-23 | 2023-09-25 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 변형된 trem의 조성물 및 이의 용도 |
| MX2023007902A (es) * | 2020-12-31 | 2023-08-16 | Univ Iowa Res Found | Composiciones de arn de transferencia supresor sentido y usos y funciones relacionados. |
| US20240175048A1 (en) * | 2021-02-25 | 2024-05-30 | Riboz, Llc | Engineered expression constructs to increase protein expression from synthetic ribonucleic acid (rna) |
| EP4334450A4 (en) * | 2021-05-05 | 2025-06-18 | Tevard Biosciences, Inc. | Methods and compositions for treating a premature termination codon-mediated disorder |
| CN113308463A (zh) * | 2021-05-12 | 2021-08-27 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 经过反密码子编辑的tRNA作为分子开关在精准控制蛋白表达及病毒复制中的应用 |
| EP4389890A4 (en) * | 2021-09-24 | 2025-12-31 | Fujifilm Corp | ARNT, AMINOACYL-ARNT, POLYPEPTIDE SYNTHESIS REAGENT, PROCESS FOR INCORPORATION OF NON-NATURAL AMINO ACIDS, PROCESS FOR PRODUCING POLYPEPTIDES, PROCESS FOR PRODUCING NUCLEIC ACID DISPLAY BANK LAYERS, NUCLEIC ACID/POLYPEPTIDE CONJUGATE, AND SCREENING PROCESS |
| US20250059538A1 (en) * | 2021-12-23 | 2025-02-20 | Shape Therapeutics Inc. | COMPOSITIONS AND METHODS OF tRNA SILENCING |
| AU2023210521A1 (en) | 2022-01-21 | 2024-08-29 | David H. Altreuter | Modified transfer rna with improved activity |
| AU2023212951A1 (en) * | 2022-01-25 | 2024-08-29 | Hc Bioscience, Inc. | Universal suppressor trnas and uses thereof |
| AU2023215397A1 (en) | 2022-02-07 | 2024-08-22 | University Of Rochester | Optimized sequences for enhanced trna expression or/and nonsense mutation suppression. |
| CN114717204B (zh) * | 2022-03-08 | 2023-12-26 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 复制缺陷型伪狂犬病病毒及其构建方法和应用 |
| CA3249261A1 (en) | 2022-04-18 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | COMPOSITIONS AND PROCESSES TO IMPROVE ADENE-ASSOCIATED VIRUS (AAV) THERAPY AND REDUCE AAV TROPISM TO THE LIVER |
| WO2023220083A1 (en) * | 2022-05-09 | 2023-11-16 | Flagship Pioneering Innovations Vi, Llc | Trem compositions and methods of use for treating proliferative disorders |
| WO2023220342A2 (en) * | 2022-05-13 | 2023-11-16 | Shape Therapeutics Inc. | Engineered tranfer rnas |
| WO2024155745A1 (en) * | 2023-01-18 | 2024-07-25 | The Broad Institute, Inc. | Base editing-mediated readthrough of premature termination codons (bert) |
| EP4652272A1 (en) * | 2023-01-18 | 2025-11-26 | The Broad Institute Inc. | Prime editing-mediated readthrough of premature termination codons (pert) |
| WO2024178172A1 (en) | 2023-02-23 | 2024-08-29 | University Of Rochester | Agents and methods for making closed-end dna thread molecules |
| WO2024197081A1 (en) | 2023-03-20 | 2024-09-26 | Hc Bioscience, Inc. | Minimally-sized dna threads for trna therapy |
| EP4442826A1 (en) | 2023-04-06 | 2024-10-09 | Universität Hamburg | Synthetic dna construct encoding transfer rna |
| EP4458967A1 (en) | 2023-05-02 | 2024-11-06 | Universität Hamburg | Pharmaceutical composition comprising multiple suppressor transfer rnas |
| WO2024243073A1 (en) * | 2023-05-19 | 2024-11-28 | University Of Iowa Research Foundation | Anti-codon engineered suppressor transfer rnas |
| WO2025080866A1 (en) * | 2023-10-10 | 2025-04-17 | Hc Bioscience, Inc. | Trna therapeutics for hemophilia |
| WO2025101685A1 (en) | 2023-11-09 | 2025-05-15 | University Of Rochester | Suppression of nonsense mutations using anticodon engineered (ace)-trnas |
| WO2025176166A1 (en) * | 2024-02-21 | 2025-08-28 | Zhuhai Codone Biotechnology Co., Ltd. | Engineered trna expression cassette |
| CN118389493B (zh) * | 2024-05-10 | 2025-04-11 | 北京大学 | 一种定点修饰的工程化tRNA及其应用 |
| CN118147231B (zh) * | 2024-05-11 | 2024-07-12 | 北京大学 | 包含工程化转运核糖核酸分子的核酸构建体及其应用 |
| WO2026006151A2 (en) | 2024-06-24 | 2026-01-02 | University Of Rochester | Functionalization of ace-trna encoding synthetic linear picovectors |
| WO2026030209A1 (en) | 2024-07-29 | 2026-02-05 | University Of Rochester | Use of decoding trnas to boost protein expression or function |
| WO2026136461A1 (en) * | 2024-12-17 | 2026-06-25 | The Broad Institute, Inc. | Prime editing-mediated readthrough of premature termination codons (pert) |
| CN120420340A (zh) * | 2025-05-09 | 2025-08-05 | 北京大学 | 用于治疗抑癌基因无义突变的抑制性转运核糖核酸 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4687737A (en) | 1982-11-12 | 1987-08-18 | Massachusetts Institute Of Technology | Mammalian suppressor genes |
| US5840702A (en) * | 1996-03-22 | 1998-11-24 | Uab Research Foundation | Cystic fibrosis treatment |
| US6531123B1 (en) | 1997-05-01 | 2003-03-11 | Lung-Ji Chang | Lentiviral vectors |
| JP2002508959A (ja) * | 1998-01-14 | 2002-03-26 | ヒューマン ジーン セラピー リサーチ インスティテュート | ヒトのサプレッサーｔＲＮＡオリゴヌクレオチド、及びそれを用いる方法 |
| CA2449950A1 (en) * | 2001-06-13 | 2002-12-27 | Masayuki Arakawa | Agents for treating diseases caused by nonsense mutation |
| WO2003033521A1 (en) | 2001-10-16 | 2003-04-24 | Massachusetts Institute Of Technology | Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides. |
| KR101423898B1 (ko) | 2005-12-14 | 2014-07-28 | 암브룩스, 인코포레이티드 | 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도 |
| GB0600948D0 (en) | 2006-01-18 | 2006-02-22 | Univ Dundee | Prevention/Treatment Of Ichthyosis Vulgaris, Atopy And Other Disorders |
| FR2902439A1 (fr) * | 2006-06-14 | 2007-12-21 | Univ Rene Descartes Paris V Et | Arn de transfert chimerique et son utilisation pour la production d'arn par une cellule |
| WO2009086497A2 (en) | 2007-12-28 | 2009-07-09 | Ardell David H | Genetic encryption |
| US20120077186A1 (en) * | 2010-05-07 | 2012-03-29 | Oregon Health & Science University | Use of cysteine-derived suppressor trnas for non-native amino acid incorporation |
| US10513699B2 (en) | 2014-09-03 | 2019-12-24 | Bioatla, Llc | Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts |
| HRP20170589T2 (hr) | 2014-12-22 | 2023-05-12 | Sandoz Ag | Varijante sekvenci |
| US20180171321A1 (en) | 2015-03-27 | 2018-06-21 | The University Of Queensland | Platform for a non-natural amino acid incorporation into proteins |
| WO2017049409A1 (en) | 2015-09-25 | 2017-03-30 | The Centre For Drug Research And Development | Compositions for promoting readthrough of premature termination codons, and methods of using the same |
| CN107177592B (zh) * | 2016-03-10 | 2021-03-30 | 北京大学 | 抑制性tRNA通读提前终止密码子疾病中的截短蛋白 |
| PL3458074T3 (pl) | 2016-05-16 | 2024-11-12 | Board Of Regents Of The University Of Texas System | KOMPOZYCJA DO DOSTARCZANIA tRNA W POSTACI NANOCZĄSTEK I SPOSOBY ICH STOSOWANIA |
| WO2018031531A1 (en) | 2016-08-08 | 2018-02-15 | President And Fellows Of Harvard College | Engineered bacteria for non-invasive imaging and therapeutic applications |
| CN110612353A (zh) * | 2017-03-03 | 2019-12-24 | 加利福尼亚大学董事会 | 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向 |
| MX2020004587A (es) | 2017-11-02 | 2021-04-12 | Univ Iowa Res Found | Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt. |
| AU2019233673B2 (en) | 2018-03-15 | 2025-05-01 | Arcturus Therapeutics, Inc. | Synthetic transfer RNA with extended anticodon loop |
| WO2020069194A1 (en) | 2018-09-26 | 2020-04-02 | Case Western Reserve University | Methods and compositions for treating a premature stop codon-mediated disorder |
| JP2022528696A (ja) | 2019-04-11 | 2022-06-15 | アークタラス テラピュウティクス、インク | アンチコドンループを延長した合成転移ｒｎａ |
| EP4041317A4 (en) | 2019-10-11 | 2024-05-22 | University of Massachusetts | RAAV-MEDIATED IN VIVO ADMINISTRATION OF ARNT SUPPRESSANTS |
| JP7712270B2 (ja) | 2019-11-01 | 2025-07-23 | テバード バイオサイエンシズ インコーポレイテッド | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| CA3160097A1 (en) | 2019-11-04 | 2021-05-14 | Flagship Pioneering, Inc. | Trem compositions for con-rare codons and related uses |
| JP2023504661A (ja) | 2019-12-02 | 2023-02-06 | シェイプ・セラピューティクス・インコーポレイテッド | 疾患の処置のための標的化トランスファーｒｎａ |
-
2018
- 2018-11-02 MX MX2020004587A patent/MX2020004587A/es unknown
- 2018-11-02 AU AU2018360055A patent/AU2018360055B2/en active Active
- 2018-11-02 CN CN202410906067.5A patent/CN119286852A/zh active Pending
- 2018-11-02 KR KR1020207015631A patent/KR102857378B1/ko active Active
- 2018-11-02 JP JP2020524637A patent/JP2021502078A/ja active Pending
- 2018-11-02 WO PCT/US2018/059085 patent/WO2019090169A1/en not_active Ceased
- 2018-11-02 WO PCT/US2018/059065 patent/WO2019090154A1/en not_active Ceased
- 2018-11-02 IL IL274356A patent/IL274356B1/en unknown
- 2018-11-02 CA CA3081692A patent/CA3081692A1/en active Pending
- 2018-11-02 BR BR112020008725-4A patent/BR112020008725A2/pt not_active Application Discontinuation
- 2018-11-02 EP EP18872286.2A patent/EP3703762A4/en active Pending
- 2018-11-02 CN CN201880085141.4A patent/CN111712248B/zh active Active
- 2018-11-02 MX MX2020004647A patent/MX2020004647A/es unknown
- 2018-11-02 AU AU2018360065A patent/AU2018360065A1/en not_active Abandoned
- 2018-11-02 CN CN201880079506.2A patent/CN111818945A/zh active Pending
- 2018-11-02 IL IL328657A patent/IL328657A/en unknown
- 2018-11-02 JP JP2020524562A patent/JP7474511B2/ja active Active
- 2018-11-02 CA CA3081737A patent/CA3081737A1/en active Pending
- 2018-11-02 RU RU2020117928A patent/RU2020117928A/ru unknown
- 2018-11-02 US US16/761,205 patent/US11661600B2/en active Active
- 2018-11-02 IL IL274396A patent/IL274396B2/en unknown
- 2018-11-02 EP EP18872570.9A patent/EP3703701A4/en active Pending
- 2018-11-02 BR BR112020008733-5A patent/BR112020008733A2/pt not_active Application Discontinuation
- 2018-11-02 RU RU2020117787A patent/RU2020117787A/ru unknown
- 2018-11-02 US US16/760,932 patent/US20230203482A1/en not_active Abandoned
- 2018-11-02 KR KR1020207015589A patent/KR102930465B1/ko active Active
-
2023
- 2023-04-21 US US18/137,942 patent/US12565649B2/en active Active
- 2023-04-21 US US18/137,931 patent/US12559749B2/en active Active
- 2023-05-24 JP JP2023085389A patent/JP7474532B2/ja active Active
-
2024
- 2024-02-02 US US18/430,760 patent/US20250115905A1/en active Pending
- 2024-02-16 JP JP2024022138A patent/JP7804358B2/ja active Active
-
2025
- 2025-03-05 JP JP2025034647A patent/JP2025111411A/ja active Pending
- 2025-11-07 JP JP2025188664A patent/JP7904651B2/ja active Active
-
2026
- 2026-01-22 US US19/457,063 patent/US20260209763A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125029T1 (el) | Τροποποιημενοι νουκλεοζιτες, νουκλεοτιδια, και νουκλεϊκα οξεα και χρησεις αυτων | |
| CY1125421T1 (el) | Ριβονουκλεϊκα οξεα που περιεχουν ν1-μεθυλο- ψευδοουρακιλες και χρησεις αυτων | |
| MY209343A (en) | Exocyclic amine substituted coumarin compounds and uses as fluorescent labels | |
| EP4328303A3 (en) | Novel use | |
| FR2981088B1 (fr) | Arn polymerases mutees | |
| ES2688623T3 (es) | Proteínas de fusión que se unen a factores de crecimiento | |
| WO2019135816A3 (en) | Novel nucleic acid modifiers | |
| MX2016007541A (es) | Moléculas modificadas de ácido nucleico y usos de las mismas. | |
| TWD187468S (zh) | 翹孤輪支架之部分 | |
| PE20081723A1 (es) | Vacuna contra el papilomavirus | |
| MX2018008135A (es) | Moleculas de acido nucleico de influenza y vacunas elaboradas a partir de las mismas. | |
| NZ597769A (en) | Proteins and nucleic acids from meningitis/sepsis-associated Escherichia Coli | |
| CY1117896T1 (el) | Εμβολιο πρωτεϊνης συντηξης | |
| BRPI0912093A2 (pt) | sistema e método para receber e/ou entregar um pacote com segurança | |
| BR112014021993A2 (pt) | detecção da variação de nucleotídeo em sequência de ácido nucleico alvo através de ensaio de clivagem e extensão de pto | |
| SG10201802281XA (en) | Assay For The Diagnosis Of Dermatophytosis | |
| RU2018117175A (ru) | Рекомбинантный микроорганизм для получения L-треонина и способ получения L-треонина с использованием указанного микроорганизма | |
| ES2493915T3 (es) | Método de detección de microorganismos | |
| TR201820975A2 (tr) | İbuprofen, Psödoefedrin ve Erdostein İçeren Uzatılmış Salım Sağlayan Farmasötik Kompozisyon | |
| NO20062384L (no) | Anvendelse av BH4 for bahandling av respiratoriske sykdommer | |
| BRPI0510385A (pt) | vetores virais polivalentes e um sistema para produção destes | |
| WO2021158982A3 (en) | Targeted translation of rna with crispr-cas13 to enhance protein synthesis | |
| Jin et al. | Genetic Incorporation of a Phenanthroline-Containing Amino Acid in Escherichia coli | |
| PL408735A1 (pl) | Aptamer DNA rozpoznający metkę argininową oraz jego zastosowanie | |
| MA37436A1 (fr) | Test moléculaire pour la détection rapide et fiable du complexe tuberculosis (mtbc) |